TITLE

Screening for Hemochromatosis: Phenotyping or Genotyping or Both?

AUTHOR(S)
Tavill, Anthony S.
PUB. DATE
June 1999
SOURCE
American Journal of Gastroenterology;Jun1999, Vol. 94 Issue 6, p1430
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
Compares phenotyping and genotyping screening for hemochromatosis. Factors considered in making recommendations for population screening for genetically determined human disorders; Significance of available data on the epidemiology and phenotypic expression of hemochromatosis to the development of algorithms for diagnosis and screening; difference between phenotyping and genotyping.
ACCESSION #
16444655

 

Related Articles

  • Hereditary haemochromatosis mutation frequencies in the general population. Bradley, Linda A.; Johnson, Dorene D.; Palomaki, Glenn E.; Haddow, James E.; Robertson, Nancy H.; Ferrie, Richard M. // Journal of Medical Screening;Mar1998, Vol. 5 Issue 1, p34 

    Objectives This study aims to expand our knowledge of the general population frequency of two mutations, C282Y and H63D, identified in the candidate gene for hereditary haemochromatosis, and to determine whether the testing can be performed using routinely obtained cheek-brush (buccal) samples....

  • Epistasis in iron metabolism: complex interactions between Cp, Mon1a, and Slc40a1 loci and tissue iron in mice. Delaby, Constance; Oustric, Vincent; Schmitt, Caroline; Muzeau, Francoise; Robreau, Anne-Marie; Letteron, Philippe; Couchi, Eric; Yu, Angel; Lyoumi, Saïd; Deybach, Jean-Charles; Puy, Herve; Karim, Zoubida; Beaumont, Carole; Grandchamp, Bernard; Demant, Peter; Gouya, Laurent // Mammalian Genome;Dec2013, Vol. 24 Issue 11/12, p427 

    Disorders of iron metabolism are among the most common acquired and constitutive diseases. Hemochromatosis has a solid genetic basis and in Northern European populations it is usually associated with homozygosity for the C282Y mutation in the HFE protein. However, the penetrance of this mutation...

  • Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population. Adams, Paul C.; Reboussin, David M.; Barton, James C.; McLaren, Christine E.; Eckfeldt, John H.; McLaren, Gordon D.; Dawkins, Fitzroy W.; Acton, Ronald T.; Harris, Emily L.; Gordeuk, Victor R.; Leiendecker-Foster, Catherine; Speechley, Mark; Snively, Beverly M.; Holup, Joan L.; Thomson, Elizabeth; Sholinsky, Phyliss // New England Journal of Medicine;4/28/2005, Vol. 352 Issue 17, p1769 

    Background: Iron overload and hemochromatosis are common, treatable conditions. HFE genotypes, levels of serum ferritin, transferrin saturation values, and self-reported medical history were studied in a multiethnic primary care population. Methods: Participants were recruited from primary care...

  • Homozygosity for Hemochromatosis: Clinical Manifestations. Edwards, Corwin Q.; Cartwright, George E.; Skolnick, Mark H.; Bernard Amos, D. // Annals of Internal Medicine;Oct80, Vol. 93 Issue 4, p519 

    Presents a study which described clinical and laboratory manifestations in hemochromatosis homozygotes. Characteristics of hemochromatosis; Methods used; Symptoms and signs of hemochromatosis at time of diagnosis; Alterations in iron status during phlebotomy.

  • Hereditary Hemochromatosis – A New Look at an Old Disease. Pietrangelo, Antonello // New England Journal of Medicine;6/3/2004, Vol. 350 Issue 23, p2383 

    The article discusses some of the important features of classic HFE-related hereditary hemochromatosis features that are shared by other phenotypic forms of hereditary hemochromatosis. Classic hereditary hemochromatosis is an autosomal recessive iron-overload disorder associated with mutation of...

  • Hereditary haemochromatosis: to screen or not. Haddow, James E.; Bradley, Linda A. // BMJ: British Medical Journal (International Edition);08/28/99, Vol. 319 Issue 7209, p531 

    Editorial. Discusses the interest of health community to hereditary hemochromatosis. Traditional view on hemochromatosis; Symptoms of the disease; Support for population screening; Factors to be considered before making a decision on screening.

  • LOW UPTAKE OF TESTING FOR HEREDITARY HAEMOCHROMATOSIS IN FIRST DEGREE RELATIVES OF C282Y HOMOZYGOTES: THE IMPLICATIONS FOR POPULATION SCREENING. McCune, C.A.; Ravine, D.; Worwood, M.; Jackson, H.A.; Hutton, D. // Gut;Apr2003 Supplement 1, Vol. 52, pA105 

    Background and Aims: The clinical significance of HFE mutations in hereditary haemochromatosis (HH) remains uncertain. Long term follow up studies of homozygotes identified by genetic screening are not available and the natural history associated with this genotype remains only partially...

  • Closing the Iron Gate. Andrews, Nancy C. // New England Journal of Medicine;1/26/2012, Vol. 366 Issue 4, p376 

    The article discusses research which was aimed at developing an oral and biologically active hepcidin for hemochromatosis treatment. It says that understanding the characteristics and functions of ferroportin and hepcidin proteins is essential to the management of large majority of iron...

  • Hemochromatosis Gene Sequence Deviations in German Patients with Porphyria Cutanea Tarda. Frank, J.; Poblete-Gutiérrez, P.; Weiskirchen, R.; Gressner, O.; Merk, H. F.; Lammert, F. // Physiological Research;2006 Supplement, Vol. 55, pS75 

    Patients with porphyria cutanea tarda (PCT) reveal a susceptibility to reversible inactivation of hepatic uroporphyrinogen decarboxylase, which might be triggered by alcohol, hepatitis C virus infection, and iron overload. Inherited factors that may predispose to clinically overt PCT also...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics